-
Product Insights
Breast Cancer Diagnostic Tests – Medical Devices Pipeline Assessment, 2020
Breast Cancer Diagnostic Tests are used for detection of cancer based on the detection and measurement of cancer-specific biomarker/antibody/antigen present in patient’s sample. GlobalData's Medical Devices sector report, “Breast Cancer Diagnostic Tests-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Breast Cancer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Breast Cancer Diagnostic Tests Pipeline Assessment report provides key information and...
-
Sector Analysis
Competitor Landscape: Rheumatoid Arthritis
Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the Rheumatoid Arthritis (RA) market, analysis of current & potential future product positioning, and forecast approval dates (by quarter) for candidates in Phase II development, or higher
-
Sector Analysis
Competitor Landscape: Spondyloarthritis
Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the spondyloarthritis (SpA) market, analysis of current & potential future product positioning, and forecast approval dates (by quarter) for candidates in Phase II development, or higher
-
Product Insights
Metastatic Breast Cancer Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Metastatic Breast Cancer Global Clinical Trials Review, H2, 2017" provides an overview of Metastatic Breast Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Metastatic Breast Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...